Partnership will focus on stem cell and tissue biology
EMBL and the Hubrecht Institute in Utrecht, the Netherlands, have signed an agreement establishing the EMBL-Hubrecht Partnership for Stem Cell and Tissue Biology. Building upon existing links between the two organisations, the partnership aims to establish a working relationship to support scientific exchange and complementarity. Working at the interface of stem cell and tissue biology, researchers in this partnership will investigate how human tissues and organs develop and are organised, advancing our understanding of a wide range of diseases, including heart degeneration, Alzheimer’s, diabetes and tumours.
“This partnership is a great opportunity for both institutions to bring forward more projects in common research priorities, such as single-cell analysis, chromatin organisation, or organ and tissue organisation,” says EMBL Director General Iain Mattaj. “We are very excited to see the first scientific collaborations between complementary research teams, but are also looking forward to sharing more closely both institutions’ core facilities and expertise in recruiting young talent.”
“I am very excited by this new partnership with EMBL,” says Alexander van Oudenaarden, Director of the Hubrecht Institute. “I am sure many new scientific opportunities will arise and I am looking forward to take a peek ‘under the hood’ of the EMBL organisation. For example, I think we will benefit from the vast experience of EMBL in recruiting international top talent. I am very proud of this direct link with the hub of molecular biology in Europe.”
EMBL institutional partnerships are close cooperative affiliations between EMBL and external institutions of comparable standard, vision and international orientation. The aim is to leverage the EMBL model together with the strengths of the partners, to create an interlinked system of excellent institutions that enhance molecular life science in Europe and the world.